The medication class, GLP-1 receptor agonists, has been in use since the mid-2000s, and no unexpected long-term safety signals have emerged with extended use
If you are on a monoamine oxidase inhibitor (MAOI) or have taken a MAOI within the past two weeks, you should not take Doxepin
In recent years, a class of diabetes and weight loss medications called Glucacon-Like Peptide-1 Receptor Agonists (often referred to as GLP-1s and semaglutide) have transformed the landscape of weight management and type 2 diabetes care
Emerging Research on GLP-1 Drugs and Addiction Recent studies suggest that GLP-1 receptor agonists, medications like semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda), may influence alcohol use and addictive behaviors by acting on the brains reward pathways
In the permutation test results of PLS-DA, Q2 was smaller than R2 and the value of the intersection of Q2 with the Y-axis was negative, proving that the model was applicable (Figure 3b)